Event Type
Disclosure
Voluntary
Variant
8-K
and Exhibit 99.1 to this report is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as a
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Daré Bioscience corporate presentation, dated January 6, 2026 104 Cover Page Inter